|
8 Companies |
|
6 Products |
|
6 Products |
|
4 Mechanisms of Action |
|
0 Trials |
|
15 News |
|
- | Venofer (iron sucrose complex) / Vifor, Daiichi Sankyo
Enrollment change, Trial withdrawal: Study of the Effects of Iron on Lung Blood Pressure at High Altitude (clinicaltrials.gov) - May 15, 2017
P2, N=0, Withdrawn, Sponsor: University of Oxford
N=26 --> 0 | Suspended --> Withdrawn
- Adempas (riociguat) / Bayer, Merck (MSD)
Trial completion, Enrollment change: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude (clinicaltrials.gov) - Jan 25, 2016
P4, N=28, Completed, Sponsor: Richard Moon
N=26 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed | N=20 --> 28
- Adempas (riociguat) / Bayer, Merck (MSD)
Enrollment closed, Trial primary completion date: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude (clinicaltrials.gov) - Dec 10, 2015
P4, N=20, Active, not recruiting, Sponsor: Richard Moon
Active, not recruiting --> Completed | N=20 --> 28 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Dec 2015
- Venofer (iron sucrose complex) / Vifor, Daiichi Sankyo
Trial primary completion date: Study of the Effects of Iron on Lung Blood Pressure at High Altitude (clinicaltrials.gov) - Aug 14, 2015
P2, N=26, Suspended, Sponsor: University of Oxford
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Oct 2009 --> Jan 2020
- Adempas (riociguat) / Bayer, Merck (MSD)
Enrollment open, Trial primary completion date: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude (clinicaltrials.gov) - Dec 10, 2014
P4, N=20, Recruiting, Sponsor: Richard Moon
Trial primary completion date: Oct 2009 --> Jan 2020 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2014 --> Sep 2015
- Enrollment change: Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders (clinicaltrials.gov) - May 13, 2014
P=N/A, N=125, Completed, Sponsor: University of Zurich
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2014 --> Sep 2015 N=96 --> 125
- Trial completion: Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders (clinicaltrials.gov) - May 13, 2014
P=N/A, N=125, Completed, Sponsor: University of Zurich
N=96 --> 125 Active, not recruiting --> Completed
- Adempas (riociguat) / Bayer, Merck (MSD)
New P4 trial: Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude (clinicaltrials.gov) - Dec 29, 2013
P4, N=20, Not yet recruiting, Sponsor: Richard Moon
- Trial completion: Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction (clinicaltrials.gov) - Sep 4, 2013
P=N/A, N=30, Completed, Sponsor: University of Heidelberg
Active, not recruiting --> Completed Recruiting --> Completed
- Bambec (bambuterol) / Teva
Trial completion: The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension (clinicaltrials.gov) - Feb 21, 2013
P1, N=20, Completed, Sponsor: Norwegian Armed Forces Medical Service
Recruiting --> Completed Recruiting --> Completed
- ambrisentan / Generic mfg., aminophylline / Generic mfg.
Trial completion: GQ01: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers (clinicaltrials.gov) - Nov 14, 2012
P1, N=18, Completed, Sponsor: Thies Schroeder
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders (clinicaltrials.gov) - Sep 11, 2012
P=N/A, N=96, Active, not recruiting, Sponsor: University of Zurich
Recruiting --> Completed Recruiting --> Active, not recruiting
- acetazolamide / Generic mfg., tadalafil / Generic mfg.
Trial completion: Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention (clinicaltrials.gov) - Sep 6, 2012
P=N/A, N=55, Completed, Sponsor: Sheba Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- Bambec (bambuterol) / Teva
New P1 trial: The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension (clinicaltrials.gov) - Mar 27, 2012
P1, N=20, Completed, Sponsor: Norwegian Armed Forces Medical Service
- ambrisentan / Generic mfg., aminophylline / Generic mfg.
New P1 trial: GQ01: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers (clinicaltrials.gov) - Feb 8, 2012
P1, N=18, Completed, Sponsor: Thies Schroeder